Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: Current Status
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1007/s00005-011-0152-z.pdf
Reference114 articles.
1. Al-Ali HK, Brand R, van Biezen A et al (2007) A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Leukemia 21:1945–1951
2. Alessandrino EP, Della Porta MG, Bacigalupo A et al (2008) WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 112:895–902
3. Alyea EP, Kim HT, Ho V et al (2006) Impact of conditioning regimen intensity on outcome of allogeneic hematopoietic cell transplantation for advanced acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant 12:1047–1055
4. Armand P, Kim HT, Cutler CS et al (2007a) Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109:4586–4588
5. Armand P, Kim HT, DeAngelo DJ et al (2007b) Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation. Biol Blood Marrow Transplant 13:655–664
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of copy neutral loss of heterozygosity and total genome aberrations on survival in myelodysplastic syndrome;Modern Pathology;2017-12-15
2. Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes;Current Pharmaceutical Design;2016-10-03
3. Emerging biological therapies for the treatment of myelodysplastic syndromes;Expert Opinion on Emerging Drugs;2016-07-02
4. Should elderly patients with higher-risk myelodysplastic syndromes undergo allogeneic hematopoietic stem cell transplantation?;Expert Review of Hematology;2013-10
5. Current therapy of myelodysplastic syndromes;Blood Reviews;2013-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3